{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:18:05Z","timestamp":1778800685534,"version":"3.51.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/wnf.0b013e31822511c4","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T17:02:19Z","timestamp":1310144539000},"page":"170-173","source":"Crossref","is-referenced-by-count":14,"title":["The Dubious Effect of Milnacipran for the Treatment of Burning Mouth Syndrome"],"prefix":"10.1097","volume":"34","author":[{"given":"Koreaki","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1592\/phco.25.3.396.61600","article-title":"Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder.","volume":"25","author":"Kirwin","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R3-9-20210203","first-page":"42","article-title":"New hope in the treatment of painful symptoms in depression.","volume":"4","author":"Briley","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","article-title":"Treatment of pain syndromes with venlafaxine.","volume":"24","author":"Grothe","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/WNF.0b013e3181cb5793","article-title":"Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region.","volume":"33","author":"Ito","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.wnf.0000145507.07261.a6","article-title":"Effectiveness of milnacipran for the treatment of chronic pain: a case series.","volume":"27","author":"Kamata","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hup.521","article-title":"Milnacipran for the treatment of chronic pain.","volume":"18","author":"Kamata","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1752-7325.2006.tb04081.x","article-title":"Linguistic adaptation and validation of the General Oral Health Assessment Index (GOHAI) in an elderly Japanese population.","volume":"66","author":"Naito","year":"2006","journal-title":"J Public Health Dent"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0895-4356(98)00096-1","article-title":"Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey.","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neures.2008.10.002","article-title":"Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.","volume":"63","author":"Ikeda","year":"2009","journal-title":"Neurosci Res"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/bja\/75.2.217","article-title":"Descending control of pain.","volume":"75","author":"Stamford","year":"1995","journal-title":"Br J Anaesth"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4088\/JCP.v63n0501","article-title":"The psychopharmacology of painful physical symptoms in depression.","volume":"63","author":"Stahl","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1819.2008.01806.x","article-title":"Two cases of burning mouth syndrome treated with olanzapine.","volume":"62","author":"Ueda","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/WNF.0b013e3181f5169d","article-title":"Milnacipran for chronic pain in the orofacial region.","volume":"33","author":"Pae","year":"2010","journal-title":"Clin Neuropharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31822511c4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:14:48Z","timestamp":1620976488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201107000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31822511c4","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}